SCHEMBL24267673

SCHEMBL24267673

CC(C)(C)OC(=O)N1CC2C=CCC1C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
NR1H2 P55055 1/20 0.37
F13A1 P00488 1/20 0.35
TGM2 P21980 1/20 0.35
TGM1 P22735 1/20 0.35
PREP P48147 1/20 0.35
AR P10275 1/20 0.35
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
PARP1 P09874 1/20 0.34
GPR119 Q8TDV5 4/20 0.33
CCR2 P41597 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898643 0.80 CHRM2 (0.46) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL4898628 0.80 CHRM2 (0.46) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL4891480 0.80 CHRM2 (0.46) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL4891486 0.80 CHRM2 (0.46) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL26046497 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL1711301 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL6097554 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL1711248 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL1711809 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2
SCHEMBL12275013 0.76 CHRM2 (0.42) HSD11B1CHRM2CHRM1CHRM3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3957633-A1 A CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND USE THEREOF Hinova Pharmaceuticals Inc. (CN) 2022-02-23 EP disclosed